about
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findingsMethotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity.Hepatotoxicity of methotrexate in rheumatic diseases.Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.An unusual case of acute methotrexate toxicity manifesting as ulcers on psoriatic plaques in an elderly male.Current treatment of psoriasis.Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesMethotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies.Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?Methotrexate in rheumatoid arthritis: an update.Psoriasis therapy: a current perspective.Oral methotrexate in the treatment of rheumatoid arthritis: allergic agranulocytosis?Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.Malignant melanoma and squamous cell carcinoma in a patient treated for severe pustular psoriasis.Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury.End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome.Effect of captopril and telmisartan on methotrexate-induced hepatotoxicity in rats: impact of oxidative stress, inflammation and apoptosis.Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study.Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment
P2860
Q33563716-67A88DF4-418A-4811-B685-84F6A789FEC2Q33563722-EF3BD95D-F270-4A42-A8D4-15F15407FB3CQ33841403-32C569AC-1B32-403A-AD8A-8E22442A828AQ34684662-2CEED321-449B-451A-B9F1-AC3CE4FC2F93Q35109287-49E73BE4-D360-4E78-95DD-F9B151DCD934Q35929533-E8AA6E35-5590-4238-992A-C3ABAD1D0227Q36414505-6D711990-9ED7-4EE4-955E-6327A2C78D7FQ36683921-6180E7D4-AF81-4E61-8469-778FCA1685EBQ36724093-03E665D3-D415-492A-8B65-97FBEB6C6A11Q38194199-0327ACE2-226B-4048-9019-E2AC0999EF18Q38537104-0F9B24E8-1724-4924-B9A4-6AAB99C3DC55Q39746666-7C2008E4-C50A-41FA-85F4-FD625C75DB1DQ40108340-6E190D85-D138-4B44-A289-B5A52101F083Q41198616-45D8DB8D-358D-43B8-8D23-AF62766E4DB9Q42219349-24C01E85-1798-4FDA-936F-E0661884F33EQ44055093-C0077929-6DE4-4054-A383-8DEA562616CAQ45711313-3D03BA92-7306-4805-8A6C-A8F18BBFCB5DQ46699120-2A9B455D-991F-4A2E-8728-9CE6CCF79DA5Q51717087-5C9380CA-1C22-4CFD-BFA6-8D8E910C2927Q53950768-AB23D77A-D5F6-4B34-B81E-9376AC293ACFQ54149961-8AE452A8-205E-4497-BA08-E259EAA44CD8Q58708624-4C7A6B4F-93E7-44C7-8CB2-E8C490DF843E
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Methotrexate guidelines--revised.
@en
type
label
Methotrexate guidelines--revised.
@en
prefLabel
Methotrexate guidelines--revised.
@en
P2093
P1476
Methotrexate guidelines--revised.
@en
P2093
G D Weinstein
H H Roenigk
H I Maibach
R Auerbach
P304
P356
10.1016/S0190-9622(82)80064-9
P407
P577
1982-02-01T00:00:00Z